« Back to Record
Citation APA

Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M. J. M., Tokunaga, E., Tsurutani, J., Ueno, N. T., Prat, A., Chae, Y. S., Lee, K. S., Niikura, N., Park, Y. H., Xu, B., Wang, X., Gil-Gil, M., Li, W., Pierga, J. Y. V. J., Im, S. –., Moore, H. C. F., Rugo, H. H., Yerushalmi, R., Zagouri, F., Gombos, A., Kim, S.-B., Liu, Q., Luo, T., Saura, C., Schmid, P., Sun, T., Gambhire, D., Yung, L., Wang, Y., Singh, J., Vitazka, P., Meinhardt, G., Harbeck, N., & Cameron, D. A. (2022). Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. The New England journal of medicine, 387(1), 9-20. doi:10.1056/NEJMoa2203690


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346888

Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M. J. M., Tokunaga, E., Tsurutani, J., Ueno, N. T., Prat, A., Chae, Y. S., Lee, K. S., Niikura, N., Park, Y. H., Xu, B., Wang, X., Gil-Gil, M., Li, W., Pierga, J. Y. V. J., Im, S. –., Moore, H. C. F., Rugo, H. H., Yerushalmi, R., Zagouri, F., Gombos, A., Kim, S.-B., Liu, Q., Luo, T., Saura, C., Schmid, P., Sun, T., Gambhire, D., Yung, L., Wang, Y., Singh, J., Vitazka, P., Meinhardt, G., Harbeck, N., & Cameron, D. A. (2022). Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. The New England journal of medicine, 387(1), 9-20. doi:10.1056/NEJMoa2203690